MedPath

Proparacaine Hydrochloride

apexa™Proparacaine Hydrochloride

Approved
Approval ID

66e8723a-620c-42ed-a43e-cfa30014e1dc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2022

Manufacturers
FDA

MWI

DUNS: 019926120

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Proparacaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13985-611
Application NumberANDA040277
Product Classification
M
Marketing Category
C73584
G
Generic Name
Proparacaine Hydrochloride
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMarch 27, 2015
FDA Product Classification

INGREDIENTS (6)

GlycerinInactive
Code: PDC6A3C0OX
Classification: IACT
Proparacaine HydrochlorideActive
Quantity: 5 mg in 1 mL
Code: U96OL57GOY
Classification: ACTIB
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Benzalkonium ChlorideInactive
Code: F5UM2KM3W7
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Proparacaine Hydrochloride - FDA Drug Approval Details